Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
Study sponsor: Jazz Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-20Actual
Enrollment · participants47Actual
Source updated2025-02-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.